Chapter 1. Executive Summary
Chapter 2. Scope Of The Study
2.1. Market Definition
2.2. Scope Of The Study
2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends
4.1. Supply/ Value Chain Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat Of New Entrants
4.2.2. Bargaining Power Of Buyers
4.2.3. Bargaining Power Of Suppliers
4.2.4. Threat Of Substitutes
4.2.5. Industry Rivalry
4.3. Impact of COVID-19 on Antibiotics Market
4.3.1. Impact on Market Size
4.3.2. End User Trend, Preferences and Budget Impact
4.3.3. Regulatory Framework/Government Policies
4.3.4. Key Players Strategy to Tackle Negative Impact
4.3.5. Opportunity Window
Chapter 5. Market Dynamics
5.1. Introduction
5.2. DRO Analysis
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
Chapter 6. Global Antibiotics Market, By Class
6.1. Introduction
6.2. Beta Lactam & Beta Lactamase Inhibitors
6.3. Quinolone
6.4. Macrolide
6.5. Others
Chapter 7. Global Antibiotics Market, By Drug Origin
7.1. Introduction
7.2. Natural
7.3. Semisynthetic
7.4. Synthetic
Chapter 8. Global Antibiotics Market, By Spectrum of Activity
8.1. Introduction
8.2. Broad-spectrum Antibiotic
8.3. Narrow-spectrum Antibiotic
Chapter 9. Global Antibiotics Market, By Region
9.1. Introduction
9.2. North America
9.2.1. Introduction
9.2.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.3. Market Size and Forecast, By Country, 2020 - 2028
9.2.4. Market Size and Forecast, By Class, 2020 - 2028
9.2.5. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.2.6. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.2.7. US
9.2.7.1. Introduction
9.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.7.3. Market Size and Forecast, By Class, 2020 - 2028
9.2.7.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.2.7.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.2.8. Canada
9.2.8.1. Introduction
9.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.8.4. Market Size and Forecast, By Class, 2020 - 2028
9.2.8.5. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.2.8.6. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.3. Europe
9.3.1. Introduction
9.3.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.3. Market Size and Forecast, By Country, 2020 - 2028
9.3.4. Market Size and Forecast, By Class, 2020 - 2028
9.3.5. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.3.6. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.3.7. Germany
9.3.7.1. Introduction
9.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.7.3. Market Size and Forecast, By Class, 2020 - 2028
9.3.7.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.3.7.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.3.8. France
9.3.8.1. Introduction
9.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.8.3. Market Size and Forecast, By Class, 2020 - 2028
9.3.8.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.3.8.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.3.9. UK
9.3.9.1. Introduction
9.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.9.3. Market Size and Forecast, By Class, 2020 - 2028
9.3.9.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.3.9.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.3.10. Italy
9.3.10.1. Introduction
9.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.10.3. Market Size and Forecast, By Class, 2020 - 2028
9.3.10.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.3.10.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.3.11. Rest Of Europe
9.3.11.1. Introduction
9.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.11.3. Market Size and Forecast, By Class, 2020 - 2028
9.3.11.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.3.11.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.3. Market Size and Forecast, By Country, 2020 - 2028
9.4.4. Market Size and Forecast, By Class, 2020 - 2028
9.4.5. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.4.7. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.4.8. China
9.4.8.1. Introduction
9.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.8.3. Market Size and Forecast, By Class, 2020 - 2028
9.4.8.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.4.8.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.4.9. India
9.4.9.1. Introduction
9.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.9.3. Market Size and Forecast, By Class, 2020 - 2028
9.4.9.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.4.9.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.4.10. Japan
9.4.10.1. Introduction
9.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.10.3. Market Size and Forecast, By Class, 2020 - 2028
9.4.10.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.4.10.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.4.11. South Korea
9.4.11.1. Introduction
9.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.11.3. Market Size and Forecast, By Class, 2020 - 2028
9.4.11.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.4.11.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.4.12. Rest Of Asia-Pacific
9.4.11.1. Introduction
9.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.12.3. Market Size and Forecast, By Class, 2020 - 2028
9.4.12.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.4.12.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.5. Rest Of The World (RoW)
9.5.1. Introduction
9.5.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.3. Market Size and Forecast, By Class, 2020 - 2028
9.5.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.5.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.5.6. Market Size and Forecast, By Region, 2020 - 2028
9.5.7. South America
9.5.7.1. Introduction
9.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.7.3. Market Size and Forecast, By Class, 2020 - 2028
9.5.7.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.5.7.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
9.5.8. Middle East & Africa
9.5.8.1. Introduction
9.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.8.3. Market Size and Forecast, By Class, 2020 - 2028
9.5.8.4. Market Size and Forecast, By Drug Origin, 2020 - 2028
9.5.8.5. Market Size and Forecast, By Spectrum of Activity, 2020 - 2028
Chapter 10. Competitive Landscape
10.1. Introduction
10.2. Vendor Share Analysis, 2020/Key Players Positioning 2020
Chapter 11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Business Overview
11.1.2. Financial Analysis
11.1.3. Product Portfolio
11.1.4. Recent Development and Strategies Adopted
11.1.5. SWOT Analysis
11.2. Allergan Plc
11.2.1. Business Overview
11.2.2. Financial Analysis
11.2.3. Product Portfolio
11.2.4. Recent Development and Strategies Adopted
11.2.5. SWOT Analysis
11.3. F.Hoffmann-La Roche Ltd.
11.3.1. Business Overview
11.3.2. Financial Analysis
11.3.3. Product Portfolio
11.3.4. Recent Development and Strategies Adopted
11.3.5. SWOT Analysis
11.4. GlaxoSmithKline Plc
11.4.1. Business Overview
11.4.2. Financial Analysis
11.4.3. Product Portfolio
11.4.4. Recent Development and Strategies Adopted
11.4.5. SWOT Analysis
11.5. Merck & Co. Inc
11.5.1. Business Overview
11.5.2. Financial Analysis
11.5.3. Product Portfolio
11.5.4. Recent Development and Strategies Adopted
11.5.5. SWOT Analysis
11.6. Mylan N.V
11.6.1. Business Overview
11.6.2. Financial Analysis
11.6.3. Product Portfolio
11.6.4. Recent Development and Strategies Adopted
11.6.5. SWOT Analysis
11.7. Novartis International AG
11.7.1. Business Overview
11.7.2. Financial Analysis
11.7.3. Product Portfolio
11.7.4. Recent Development and Strategies Adopted
11.7.5. SWOT Analysis
11.8. Pfizer Inc
11.8.1. Business Overview
11.8.2. Financial Analysis
11.8.3. Product Portfolio
11.8.4. Recent Development and Strategies Adopted
11.8.5. SWOT Analysis
11.9. Teva Pharmaceutical Industries Ltd.
11.9.1. Business Overview
11.9.2. Financial Analysis
11.9.3. Product Portfolio
11.9.4. Recent Development and Strategies Adopted
11.9.5. SWOT Analysis
11.10. Sanofi
11.10.1. Business Overview
11.10.2. Financial Analysis
11.10.3. Product Portfolio
11.9.4. Recent Development and Strategies Adopted
11.9.5. SWOT Analysis
Chapter 12. Key Takeaways